Sarepta Therapeutics (NASDAQ:SRPT) fell 11% premarket on Monday after announcing the U.S. FDA has placed a clinical hold on its investigational gene therapy trials for limb girdle muscular dystrophy ...
InvestorsHub on MSN
Lexeo Therapeutics shares slide following PKP2 gene therapy update
Shares of Lexeo Therapeutics (NASDAQ:LXEO) dropped about 17% on Monday after the company published interim Phase I/II results for its PKP2 gene therapy candidate, LX2020, being developed for ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. WASHINGTON (AP) — Shares of drugmaker ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results